Onion bulb extract can both reverse and prevent colitis in mice via inhibition of pro-inflammatory signaling molecules and neutrophil activity

PLoS One. 2020 Oct 23;15(10):e0233938. doi: 10.1371/journal.pone.0233938. eCollection 2020.

Abstract

Background: Onion is one of the most commonly used plants in the traditional medicine for the treatment of various diseases. We recently demonstrated the anti-inflammatory properties of onion bulb extract (OBE) in reducing colitis severity in mice when administered at the same time of colitis induction. However, whether onion can reverse established colitis or even prevent its development has not been investigated.

Hypothesis: To test 1. whether OBE can reduce colitis severity when given either before (preventative approach) or after (treatment approach) colitis induction and if so, 2. what are the mechanisms by which onion can achieve these effects.

Methods: Colitis was induced by dextran sulfate sodium (DSS) administration using treatment and preventative approaches. The severity of the inflammation was determined by the gross and histological assessments. The colonic level/activity of pro-inflammatory molecules and immune cell markers was assessed by immunofluorescence and western blotting analysis. In vitro neutrophil superoxide release and survival was assessed by chemilumenecense and Annexin-V/7AAD assays respectively.

Results: OBE treatment significantly reduced colitis severity in both approaches, the colonic expression/activity profile of pro-inflammatory molecules, inhibited WKYMVm-induced superoxide release, and increased spontaneous apoptosis of neutrophils in vitro.

Conclusions: OBE can be used as an effective option in the prevention and/or the treatment of established colitis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / administration & dosage*
  • Anti-Inflammatory Agents / chemistry
  • Anti-Inflammatory Agents / pharmacology
  • Colitis / chemically induced
  • Colitis / drug therapy*
  • Colitis / metabolism
  • Cyclooxygenase 2 / metabolism
  • Dextran Sulfate / adverse effects
  • Disease Models, Animal
  • Gene Expression Regulation / drug effects
  • Mice
  • Mice, Inbred BALB C
  • Onions / chemistry*
  • Phosphorylation
  • Plant Extracts / administration & dosage*
  • Plant Extracts / chemistry
  • Plant Extracts / pharmacology
  • Proto-Oncogene Proteins c-akt / metabolism
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Plant Extracts
  • Dextran Sulfate
  • Ptgs2 protein, mouse
  • Cyclooxygenase 2
  • Proto-Oncogene Proteins c-akt

Grants and funding

This work was supported by Kuwait Foundation for the Advancement of Sciences (KFAS) (grant number: P11613PT01). Parts of this work were supported by grant SRUL02/13 to the Research Unit for Genomics, Proteomics and Cellomics Studies (OMICS), Kuwait University. We would like to thank Dr. Ananthalakshmi KV for the technical help, the histology unit in the faculty of Allied Health, and the animal unit in Health Science Center, Kuwait University.